🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

RBC keeps outperform rating on Acadia Healthcare stock, eyes buy on weakness

EditorIsmeta Mujdragic
Published 05/22/2024, 11:21 AM
ACHC
-

On Wednesday, RBC Capital maintained its Outperform rating and $94.00 price target for Acadia Healthcare (NASDAQ:ACHC).

The firm highlighted the stock's recent decline of approximately 25% since late February as an appealing opportunity for investors.

RBC Capital's stance is supported by the company's favorable position in the market, which is expected to benefit from long-term industry trends and diminishing labor pressures. The firm's outlook remains unchanged, reinforcing its confidence in Acadia Healthcare with a steady price target.

InvestingPro Insights

As investors consider RBC Capital's optimistic outlook on Acadia Healthcare (NASDAQ:ACHC), real-time data and insights from InvestingPro provide additional context for informed decision-making. The company's market capitalization stands at $6.06 billion, indicating a significant presence in its industry. Despite recent challenges, with the stock trading near its 52-week low, analysts predict a turnaround with expected net income growth this year. This aligns with RBC Capital's assessment, suggesting that the current low price could represent a buying opportunity.

InvestingPro data also shows a revenue growth of 10.92% over the last twelve months as of Q1 2024, reflecting the company's ability to increase sales in a competitive environment. Additionally, the adjusted P/E ratio is forecasted to improve significantly to 5.82, hinting at potential undervaluation compared to historical earnings.

InvestingPro Tips further reveal that while nine analysts have revised their earnings estimates downwards for the upcoming period, the consensus remains that Acadia Healthcare will be profitable this year. It is important to note, however, that the company does not pay dividends, which may be a consideration for income-focused investors.

For those seeking a deeper analysis, there are additional InvestingPro Tips available that could provide further insights into Acadia Healthcare's prospects. To explore these, investors can visit https://www.investing.com/pro/ACHC and use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. With the current market dynamics, these insights could prove valuable in making a well-informed investment decision.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.